JP Morgan Comments on 4Q Results for Abbott Laboratories


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


JP Morgan published a research report today providing color on Abbott Laboratories' (NYSE: ABT) 4Q earning results. The investment firm has a Neutral rating on Abbott Laboratories.In the report, JP Morgan writes, "Abbott reported 4Q results this morning that were mostly in line with Street consensus. EPS of $1.45 (+11.8%) were a penny above consensus and in line with our thinking. Revenues of $10.377B were up 4.1% reported and 3.8% organic. On a reported basis, sales were $253M below the Street and $112M below our forecast"Shares of Abbott Laboratories are currently trading at $55.04, down 1.68% from yesterday's close.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorAnalyst Ratings